홈케어 검사 시장 규모, 점유율, 동향 분석 리포트 : 연령별, 샘플별, 검사 유형별, 유통 채널별, 제품별, 지역별, 부문별 예측(2025-2030년)

Home Care Testing Market Growth & Trends:

The global home care testing market size is estimated to reach USD 17.95 billion by 2030, registering to grow at a CAGR of 9.36% from 2025 to 2030 according to a new report by Grand View Research, Inc. The growth of the market is attributed to factors, such as increasing demand for convenient and accessible healthcare solutions, growing focus on preventative healthcare and wellness, and technological advancements.An increase in technological advancements is another major factor contributing to the market growth. There have been significant advances in diagnostic technologies, such as digital imaging, molecular diagnostics, and lab-on-a-chip systems, which have enabled the development of innovative and effective at-home testing devices. In March 2023, Cue Health, a healthcare technology company, expanded its Cue Care platform with the launch of a suite of at-home diagnostic tests.

The tests are designed to provide individuals with quick and accurate results, allowing them to take control of their health and wellness. The new tests include a range of options, such as tests for COVID-19, influenza, and Respiratory Syncytial Virus (RSV).Furthermore, home care testing has helped to reduce healthcare costs. By enabling patients to conduct their own tests at home, healthcare providers can save on the cost of labor and infrastructure needed to perform testing in a healthcare setting. This can help make healthcare more affordable and accessible for patients, particularly those with chronic conditions requiring frequent testing. In addition, home care testing has increased accessibility for patients in rural or remote areas who may not have easy access to healthcare facilities.

By enabling patients to conduct tests at home, healthcare providers reach patients who might have difficulty accessing healthcare services.The pandemic has highlighted the importance of regular monitoring and early detection of diseases, which has boosted the demand for home care testing kits. Companies have been developing new technologies and solutions to address the growing demand for quick and accurate testing solutions. This has led to the development of a range of new home care testing products, including rapid antigen tests, antibody tests, and PCR tests, which have all been used to help diagnose and monitor COVID-19. In March 2023, Lucira Health received FDA authorization for its over-the-counter (OTC) flu and COVID-19 test. The test enables individuals to test themselves for COVID-19 and the flu at home, without the need for a healthcare provider.

Home Care Testing Market Report Highlights:

• Based on age, the geriatric segment captured the highest market share in 2024 due to the presence of the geriatric population coupled with a highincidence of chronic diseases.
• Based on sample, the urine sample segment dominated the market in 2024. Advances in technology have led to more accurate and reliable urine sample testing, allowing for earlier detection and treatment of health conditions.
• Based on test type, the infectious disease segment is expected to dominate the market in 2024. The growth of the segment is attributed to factors, such as increasing cases of infectious diseases globally and a high number of product approvals.
• Based on distribution channel, the retail pharmacies segment is expected to dominate the market in 2024.These are easily accessible to consumers, with many located in convenient locations, such as shopping centers and grocery stores.
• Based on product, the strip segment dominated the market in 2024. The strip tests are relatively inexpensive & easy to use and can be performed at home without the need for specialized equipment.
• North America dominated the market and accounted for the largest revenue share of 33.71% in 2024 owing to the presence geriatric population and well-developed healthcare infrastructure.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Age Segment
  • 1.2.2. Sample Segment
  • 1.2.3. Test Type Segment
  • 1.2.4. Distribution Channel Segment
  • 1.2.5. Product Segment
• 1.3. Information analysis
  • 1.3.1. Market formulation & data visualization
• 1.4. Data validation & publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Total Market: CAGR Calculation
• 1.10. Objectives
  • 1.10.1. Objective 1
  • 1.10.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Global Home Care Testing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing prevalence of chronic diseases
    • 3.2.1.2. Technological advancements in diagnostic testing
    • 3.2.1.3. Increasing demand for self-monitoring and preventive healthcare
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of reimbursement
    • 3.2.2.2. Limited accuracy and reliability of some tests
• 3.3. Global Home Testing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Global Home Care Testing Market: Age Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Home Care Testing Market Age Movement Analysis
• 4.3. Global Home Care Testing Market Size & Trend Analysis, by Age, 2018 to 2030 (USD Million)
• 4.4. Pediatric
  • 4.4.1. Pediatric market estimates and forecast, 2018 - 2030 (USD Million)
• 4.5. Adult
  • 4.5.1. Adult market estimates and forecast, 2018 - 2030 (USD Million)
• 4.6. Geriatric
  • 4.6.1. Geriatric market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. Global Home Care Testing Market: Sample Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Home Care Testing Market Sample Movement Analysis
• 5.3. Global Home Care Testing Market Size & Trend Analysis, by Sample, 2018 to 2030 (USD Million)
• 5.4. Urine
  • 5.4.1. Urine market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. Saliva
  • 5.5.1. Saliva market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.6. Blood
  • 5.6.1. Blood market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Global Home Care Testing Market: Test Type Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Home Care Testing Market Test Type Movement Analysis
• 6.3. Global Home Care Testing Market Size & Trend Analysis, by Test Type, 2018 to 2030 (USD Million)
• 6.4. HIV Test Kit
  • 6.4.1. HIV test kit market estimates and forecast, 2018 - 2030 (USD Million)
• 6.5. Diabetes and Glucose Tests
  • 6.5.1. Diabetes and glucose tests market estimates and forecast, 2018 - 2030 (USD Million)
• 6.6. Cholesterol and Triglycerides Tests
  • 6.6.1. Cholesterol and triglycerides tests market estimates and forecast, 2018 - 2030 (USD Million)
• 6.7. Pregnancy Tests
  • 6.7.1. Pregnancy tests market estimates and forecast, 2018 - 2030 (USD Million)
• 6.8. Infectious Diseases Tests
  • 6.8.1. Infectious diseases tests market estimates and forecast, 2018 - 2030 (USD Million)
• 6.9. Urinary Tract Infection Tests
  • 6.9.1. Urinary tract infection tests market estimates and forecast, 2018 - 2030 (USD Million)
• 6.10. Others
  • 6.10.1. Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7. Global Home Care Testing Market: Distribution Channel Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Home Care Testing Market Distribution Channel Movement Analysis
• 7.3. Global Home Care Testing Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
• 7.4. Retail Pharmacies
  • 7.4.1. Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• 7.5. Supermarket/Hypermarket
  • 7.5.1. Supermarket/Hypermarket market estimates and forecast, 2018 - 2030 (USD Million)
• 7.6. Online Pharmacies
  • 7.6.1. Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Global Home Care Testing Market: Product Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Home Care Testing Market Product Movement Analysis
• 8.3. Global Home Care Testing Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
• 8.4. Strip
  • 8.4.1. Strip market estimates and forecast, 2018 - 2030 (USD Million)
• 8.5. Cassette
  • 8.5.1. Cassette market estimates and forecast, 2018 - 2030 (USD Million)
• 8.6. Panel
  • 8.6.1. Panel market estimates and forecast, 2018 - 2030 (USD Million)
• 8.7. Midstream
  • 8.7.1. Midstream market estimates and forecast, 2018 - 2030 (USD Million)
• 8.8. Dip Card
  • 8.8.1. Dip card market estimates and forecast, 2018 - 2030 (USD Million)
• 8.9. Others
  • 8.9.1. Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9. Home Care Testing Market: Regional Estimates & Trend Analysis

• 9.1. Regional Dashboard
• 9.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
• 9.3. North America
  • 9.3.1. U.S.
    • 9.3.1.1. Key country dynamics
    • 9.3.1.2. Regulatory framework/ reimbursement structure
    • 9.3.1.3. Competitive scenario
    • 9.3.1.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.3.2. Canada
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Regulatory framework/ reimbursement structure
    • 9.3.2.3. Competitive scenario
    • 9.3.2.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.3.3. Mexico
    • 9.3.3.1. Key country dynamics
    • 9.3.3.2. Regulatory framework/ reimbursement structure
    • 9.3.3.3. Competitive scenario
    • 9.3.3.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
• 9.4. Europe
  • 9.4.1. UK
    • 9.4.1.1. Key country dynamics
    • 9.4.1.2. Regulatory framework/ reimbursement structure
    • 9.4.1.3. Competitive scenario
    • 9.4.1.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.4.2. Germany
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Regulatory framework/ reimbursement structure
    • 9.4.2.3. Competitive scenario
    • 9.4.2.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.4.3. France
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Regulatory framework/ reimbursement structure
    • 9.4.3.3. Competitive scenario
    • 9.4.3.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.4.4. Italy
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Regulatory framework/ reimbursement structure
    • 9.4.4.3. Competitive scenario
    • 9.4.4.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.4.5. Spain
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Regulatory framework/ reimbursement structure
    • 9.4.5.3. Competitive scenario
    • 9.4.5.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.4.6. Norway
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Regulatory framework/ reimbursement structure
    • 9.4.6.3. Competitive scenario
    • 9.4.6.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.4.7. Sweden
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Regulatory framework/ reimbursement structure
    • 9.4.7.3. Competitive scenario
    • 9.4.7.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.4.8. Denmark
    • 9.4.8.1. Key country dynamics
    • 9.4.8.2. Regulatory framework/ reimbursement structure
    • 9.4.8.3. Competitive scenario
    • 9.4.8.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Japan
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Regulatory framework/ reimbursement structure
    • 9.5.1.3. Competitive scenario
    • 9.5.1.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5.2. China
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework/ reimbursement structure
    • 9.5.2.3. Competitive scenario
    • 9.5.2.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5.3. India
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory framework/ reimbursement structure
    • 9.5.3.3. Competitive scenario
    • 9.5.3.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5.4. Australia
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Regulatory framework/ reimbursement structure
    • 9.5.4.3. Competitive scenario
    • 9.5.4.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5.5. South Korea
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Regulatory framework/ reimbursement structure
    • 9.5.5.3. Competitive scenario
    • 9.5.5.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.5.6. Thailand
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Regulatory framework/ reimbursement structure
    • 9.5.6.3. Competitive scenario
    • 9.5.6.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
• 9.6. Latin America
  • 9.6.1. Brazil
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Regulatory framework/ reimbursement structure
    • 9.6.1.3. Competitive scenario
    • 9.6.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.6.2. Argentina
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework/ reimbursement structure
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
• 9.7. MEA
  • 9.7.1. South Africa
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Regulatory framework/ reimbursement structure
    • 9.7.1.3. Competitive scenario
    • 9.7.1.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.7.2. Saudi Arabia
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory framework/ reimbursement structure
    • 9.7.2.3. Competitive scenario
    • 9.7.2.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.7.3. UAE
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Regulatory framework/ reimbursement structure
    • 9.7.3.3. Competitive scenario
    • 9.7.3.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
  • 9.7.4. Kuwait
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Regulatory framework/ reimbursement structure
    • 9.7.4.3. Competitive scenario
    • 9.7.4.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Company/Competition Categorization
• 10.2. Strategy Mapping
• 10.3. Company Market Position Analysis, 2024
• 10.4. List of Key Certification Providers/Scheme Owners
• 10.5. Company Profiles/Listing
  • 10.5.1. Abbott
    • 10.5.1.1. Company overview
    • 10.5.1.2. Financial performance
    • 10.5.1.3. Product benchmarking
    • 10.5.1.4. Strategic initiatives
  • 10.5.2. BD
    • 10.5.2.1. Company overview
    • 10.5.2.2. Financial performance
    • 10.5.2.3. Product benchmarking
    • 10.5.2.4. Strategic initiatives
  • 10.5.3. Quidel Corporation
    • 10.5.3.1. Company overview
    • 10.5.3.2. Financial performance
    • 10.5.3.3. Product benchmarking
    • 10.5.3.4. Strategic initiatives
  • 10.5.4. BioSure
    • 10.5.4.1. Company overview
    • 10.5.4.2. Financial performance
    • 10.5.4.3. Product benchmarking
    • 10.5.4.4. Strategic initiatives
  • 10.5.5. F. Hoffmann-La Roche Ltd.
    • 10.5.5.1. Company overview
    • 10.5.5.2. Financial performance
    • 10.5.5.3. Product benchmarking
    • 10.5.5.4. Strategic initiatives
  • 10.5.6. Nova Biomedical
    • 10.5.6.1. Company overview
    • 10.5.6.2. Financial performance
    • 10.5.6.3. Product benchmarking
    • 10.5.6.4. Strategic initiatives
  • 10.5.7. Siemens Healthcare GmbH
    • 10.5.7.1. Company overview
    • 10.5.7.2. Financial performance
    • 10.5.7.3. Product benchmarking
    • 10.5.7.4. Strategic initiatives
  • 10.5.8. ACON Laboratories, Inc.
    • 10.5.8.1. Company overview
    • 10.5.8.2. Financial performance
    • 10.5.8.3. Product benchmarking
    • 10.5.8.4. Strategic initiatives
  • 10.5.9. OraSure Technologies, Inc.
    • 10.5.9.1. Company overview
    • 10.5.9.2. Financial performance
    • 10.5.9.3. Product benchmarking
    • 10.5.9.4. Strategic initiatives
  • 10.5.10. Chembio Diagnostics, Inc.
    • 10.5.10.1. Company overview
    • 10.5.10.2. Financial performance
    • 10.5.10.3. Product benchmarking
    • 10.5.10.4. Strategic initiatives